Inflection Biosciences

0 followers

‌

Inflection Biosciences Ltd is an early stage, drug development company with a focus on discovering and developing innovative small molecule therapeutics addressing major unmet needs in cancer.

Industries

Headquarters

Stage

Employees

Links

Org chart

View full screen

Darren Cunningham

CEO and Co-Founder

Darren Cunningham

Collapse

Tess Barker

Head of Development

Frank Bonner

Head of Non-Clinical Safety

Gemma Carroll

Financial Controller

Kathy Gately

Senior Scientist (Translational Oncology)

Paul Dickinson

CMC: Preclinical and Clinical Formulation Development

David Lathbury

CMC: Process Chemistry

Gerry McGettigan

Regulatory Affairs

Teams

View all

Board of Directors

8 members

Leadership Team

8 members

CEO and Executive Team

1 members

Founding Team

1 members

Discover similar companies

Kymera Therapeutics

3 followers

Cartesian Therapeutics

1 follower

Tempus Labs

12 followers

Ultragenyx Pharmaceutical

5 followers

BenevolentAI

5 followers